SCHEMBL28219211

SCHEMBL28219211

c1cncc(-c2cccc(N3CCNCC3)c2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 8/20 0.67
HTR1A P08908 7/20 0.67
CHRNB2 P17787 2/20 0.61
CHRNA4 P43681 2/20 0.61
PIM1 P11309 1/20 0.59
PIM3 Q86V86 1/20 0.59
PIM2 Q9P1W9 1/20 0.59
CYP1A2 P05177 2/20 0.56
CYP3A4 P08684 2/20 0.56
DHFR P00374 1/20 0.56
KDM4E B2RXH2 1/20 0.56
KARS1 Q15046 1/20 0.55
CHEK1 O14757 1/20 0.52
ADRB1 P08588 2/20 0.51
HTR3E A5X5Y0 1/20 0.51
HTR3B O95264 1/20 0.51
TP53 P04637 1/20 0.51
CYP2D6 P10635 1/20 0.51
THRB P10828 1/20 0.51
CYP2C9 P11712 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6348853 0.88 CHRNB2 (0.61) HTR7HTR1ACHRNB2CHRNA4PIM1
SCHEMBL29387046 0.86 HTR7 (0.69) HTR7HTR1APIM1PIM3CYP1A2
SCHEMBL15577956 0.86 HTR7 (0.69) HTR7HTR1APIM1PIM3CYP1A2
SCHEMBL941414 0.84 PIM1 (0.65) HTR7HTR1ACHRNB2CHRNA4PIM1
Hydrochloric Acid SCHEMBL27587884 0.83 PIM1 (0.64) HTR7HTR1ACHRNB2CHRNA4PIM1
SCHEMBL16570272 0.83 CHRNB2 (0.52) HTR7HTR1ACHRNB2CHRNA4PIM1
SCHEMBL6352432 0.83 CHRNB2 (0.72) CHRNB2CHRNA4PIM1PIM3PIM2
SCHEMBL1423292 0.82 CHRNB2 (0.57) HTR7HTR1ACHRNB2CHRNA4KDM4E
SCHEMBL28721523 0.82 MEN1 (0.58) CYP1A2CYP3A4DHFRKDM4ETP53
SCHEMBL29507540 0.82 CHRNB2 (0.87) CHRNB2CHRNA4ADRB1HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137518-A As 6 inhibitor of histone deacetylase 1,3,4- oxadiazole derivatives compound and include its pharmaceutical composition 株式会社钟根堂 2018-06-08 CN disclosed